Home

iPierian is developing breakthrough therapies for
neurodegenerative disease.
 Our lead antibody, IPN007,
targets a novel form of secreted Tau that is differentially
regulated in Alzheimer’s disease, to inhibit disease progression.

 

Learn More ›